GigaGen, Inc.
Pharmaceutical company · South San Francisco, California, United States
GigaGen, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. It has received 14 US government small-business research awards (SBIR/STTR) from health agencies, $10 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $36 million sold in a notice filed in 2017.
GigaGen at a glance
What does GigaGen do?
US government research funding
14 SBIR/STTR small-business research awards from US health agencies, $10.1 million in total (2011 to 2017). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $36.1 million sold (2017).
Frequently asked questions about GigaGen
Where is GigaGen headquartered?
GigaGen, Inc. is headquartered in South San Francisco, California, United States.
What does GigaGen do?
GigaGen, Inc. is a pharmaceutical company.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- Alumis Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.